YOLFTbeta
Daihan Pharmaceutical Co.Ltd

Daihan Pharmaceutical Co.Ltd

023910 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

25,200.00KRW+350.00 (+1.41%)

Price History

Full chart

Market Stats

Previous Close24,850.00
Open24,850.00
Day Range24,850.00 – 25,300.00
52-Week Range24,000.00 – 31,200.00
Volume10.58K
Market Cap152.88B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.80%
Beta0.14
50-Day Avg26,492.00
200-Day Avg27,741.75

About

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOSungyoung Lee
  • Employees0
  • Headquarters3, Seonyu-ro 45-gil, Seoul, South Korea, 07209, Korea
  • Websitehttps://www.daihan.com

Leadership

  • Sungyoung LeeChief Executive Officer · b. 1963

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue111.71B124.28B139.44B144.44B158.72B168.76B166.08B171.46B184.27B195.91B204.19B208.61B
Growth (%)-+11.25%+12.20%+3.59%+9.89%+6.33%-1.59%+3.24%+7.47%+6.32%+4.23%+2.16%
Cost of Revenue77.81B84.46B95.82B89.65B98.47B109.27B109.54B115.42B124.03B129.99B134.41B143.79B
Gross Profit33.90B39.82B43.62B54.79B60.25B59.50B56.54B56.04B60.24B65.92B69.79B64.82B
Gross Margin30.35%32.04%31.28%37.93%37.96%35.25%34.04%32.68%32.69%33.65%34.18%31.07%
Operating Expense19.96B21.13B21.90B22.54B24.03B25.86B26.57B27.10B27.37B30.21B31.75B33.64B
Operating Income13.94B18.69B21.72B32.25B36.22B33.64B29.96B28.94B32.87B35.71B38.03B31.19B
Operating Margin12.48%15.04%15.58%22.33%22.82%19.93%18.04%16.88%17.84%18.23%18.63%14.95%
EBITDA--------43.25B45.45B49.61B42.38B
EBITDA Margin--------23.47%23.20%24.30%20.31%
Net Income10.42B13.78B17.66B24.83B28.52B28.17B17.38B22.67B24.96B28.43B33.76B27.64B
Net Income Margin9.33%11.09%12.66%17.19%17.97%16.69%10.47%13.22%13.55%14.51%16.53%13.25%
R&D67.86M356.27M410.18M382.31M458.12M392.44M689.17M790.59M567.87M1.64B1.80B2.21B
R&D as % of Total Revenue0.06%0.29%0.29%0.26%0.29%0.23%0.41%0.46%0.31%0.84%0.88%1.06%
Interest Expense000000617.06M469.27M593.43M52.47M1.81M2.69M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.37%0.27%0.32%0.03%0.00%0.00%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets131.61B138.83B160.31B184.40B234.75B246.85B253.09B272.54B276.98B294.25B324.41B347.66B
Total Liabilities67.52B61.99B67.36B68.52B94.39B80.08B71.17B69.73B51.58B46.28B48.42B47.45B
Total Equity64.10B76.84B92.94B115.88B140.36B166.78B181.92B202.81B225.40B247.97B275.99B300.21B
Cash3.81B9.25B8.77B13.05B40.48B44.74B61.30B39.01M265.51M101.50B61.30B43.97B
Total Debt-16.12B9.80B17.40B36.00B29.80B24.52B-----

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow9.48B17.98B27.92B20.45B44.94B35.26B33.63B40.62B29.00B38.86B35.64B25.60B
Investing Cash Flow-11.86B-3.85B-23.72B-20.77B-35.62B-20.78B-10.94B-11.51B193.48M-18.00B-72.63B-
Financing Cash Flow1.72B-8.73B-4.60B4.69B17.99B-10.28B-5.71B-7.41B-22.54B-10.33B-4.37B-
Capital Expenditure10.47B3.96B21.90B21.05B46.69B17.30B5.36B11.85B8.62B21.28B15.80B25.12B
Free Cash Flow------28.27B28.77B20.38B17.58B19.84B481.53M
Dividends Paid720.00M900.00M1.08B1.32B1.80B1.64B2.11B2.11B2.11B3.75B4.33B5.19B
FCF to OCF------84.06%70.83%70.27%45.24%55.67%1.88%
Dividend Paid to FCF------7.46%7.33%10.34%21.34%21.82%1078.81%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 14, 2014Nov 14, 2014Feb 5, 2015May 18, 2015Aug 14, 2015Nov 15, 2015Feb 4, 2016May 13, 2016Aug 12, 2016Nov 11, 2016Feb 9, 2017May 15, 2017Aug 13, 2017Nov 12, 2017Feb 7, 2018May 15, 2018Aug 14, 2018Nov 13, 2018Mar 12, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 13, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Feb 9, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Feb 9, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Mar 17, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------------
EPS Actual46.0130.23116.553.7478.0238.97191.27107.26163.7328.59353.53209.29387.36226.27403.80195.99454.26479.95155.46214.58542.44416.52493.18284.59441.94634.65684.66534.79693.44716.15864.46668.84897.321099.871284.27858.001117.001316.001148.001172.001073.001210.001112.911298.231162.00833.001081.00-179.24860.00933.001166.00819.241030.101155.721361.16623.701243.081252.681336.201002.461405.861363.641443.211528.611300.401054.941482.80863.201187.221148.46
Surprise----------------------------------------------------------------------
Timing---------------------Pre-market--Pre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-market--After-hoursAfter-hours--Pre-marketAfter-hoursPre-marketAfter-hoursPre-market-After-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market--Pre-market--------------

Key Statistics & Ratios

Market Cap152.88B
Enterprise Value39.95B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.71
Price / Book0.50
Revenue (TTM)216.55B
Gross Profit (TTM)63.72B
EBITDA41.78B
Profit Margin12.71%
Operating Margin14.27%
Return on Equity9.29%
Return on Assets5.43%
Shares Outstanding5.88M
Shares Float3.48M
Beta0.14
Dividend Yield3.80%
Dividend Rate1,000.00
Payout Ratio21.36%

Dividends

20251×
1000.00Dec 29, 2025
20241×
900.00Dec 27, 2024
20231×
750.00Dec 27, 2023
20221×
650.00Dec 28, 2022
20211×
400.00Dec 29, 2021
20201×
400.00Dec 29, 2020
20191×
400.00Dec 27, 2019
20181×
300.00Dec 27, 2018
20171×
300.00Dec 27, 2017
20161×
220.00Dec 28, 2016
20151×
180.00Dec 29, 2015
20141×
150.00Dec 29, 2014
20131×
120.00Dec 27, 2013
20121×
120.00Dec 27, 2012
20111×
100.00Dec 28, 2011
20101×
80.00Dec 29, 2010
20091×
60.00Dec 29, 2009
20081×
50.00Dec 29, 2008
20071×
40.00Dec 27, 2007
20061×
50.00Dec 27, 2006
20051×
50.00Dec 28, 2005
20041×
125.00Dec 29, 2004
20031×
125.00Dec 29, 2003
20021×
125.00Dec 27, 2002

Stock Splits

  • Apr 29, 200210:1